{
  "ticker": "RAD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958876",
  "id": "02958876",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250616",
  "time": "1656",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06ksr1tr8ckg8w.pdf",
  "summary": "### Substantial Holder Notice Summary (Radiopharm Theranostics Ltd - RAD):  \n\n- **Substantial Holder**: Regal Funds Management Pty Ltd & associates  \n- **Current Holdings**:  \n  - **Ordinary Shares**: 127,119,648 (5.38% voting power)  \n  - **ADS (300:1 ratio)**:  \n    - 35,276 ADS \u2192 10,582,800 ordinary share equivalents (0.45%)  \n    - 30,633 ADS \u2192 9,189,900 ordinary share equivalents (0.39%)  \n  - **Total Voting Power**: 145,362,288 (6.15% of 2,364,949,502 shares outstanding).  \n\n- **Key Changes** (since last notice):  \n  - **Major Purchases**:  \n    - 40M ordinary shares acquired on 31/03/2025 (consideration: $1.08M).  \n    - 15M ordinary shares acquired on 09/12/2024 (consideration: $584,970).  \n  - **Major Sales**:  \n    - 27.3M ordinary shares sold on 12/12/2024 (shunt transaction).  \n    - 13.9M ordinary shares sold on 03/04/2025 (consideration: $321,527).  \n  - **ADS Transactions**: 90,909 ADS acquired on 12/12/2024.  \n\n- **Dilution Event**:  \n  - Holding diluted due to issuance of 30,969,360 new shares on 11/06/2025.  \n\n**Material Impact**: Significant reduction in holding (from 8.30% to 6.15%) via net sales and dilution. Monitor for further selling pressure.  \n\n*Omitted: Non-material transactions, legal entities, and filing dates.*",
  "usage": {
    "prompt_tokens": 2485,
    "completion_tokens": 389,
    "total_tokens": 2874,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-16T07:52:20.146959"
}